Connection

XANDER WEHRENS to Pyrimidines

This is a "connection" page, showing publications XANDER WEHRENS has written about Pyrimidines.
Connection Strength

0.040
  1. An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor. Sci Transl Med. 2023 06 21; 15(701):eabq7839.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.